Name | N-(5-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide |
---|---|
Synonyms |
N-[5-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-2-(2-dimethylaminoethylmethylamino)-4-methoxyphenyl]prop-2-enamide
Mutant EGFR inhibitor |
Description | Mutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1; inhibits EGFRL858R, EGFRExon 19 deletion and EGFRT790M. |
---|---|
Related Catalog | |
Target |
EGFRL858R EGFRExon 19 deletion EGFRT790M |
References |
[1]. WO 2013014448 A1 |
Molecular Formula | C27H30ClN7O2 |
---|---|
Molecular Weight | 520.02600 |
Exact Mass | 519.21500 |
PSA | 98.41000 |
LogP | 5.29880 |
Storage condition | 2-8℃ |